Bullish Case: Nov calls dominate flow (270C delta 0.51, 280/290/300C bid) and calls traded 83% more volume than puts; bullish risk is +49% vs bearish. THC sits 2% below the 283.05 cup-base buy point with a 98/99 Composite, and November IV (~57% bid-side) shows traders paying up for near-term upside. Medicaid-cut softening under a Democratic sweep plus CommonSpirit's Conifer exit removing a weak client are supportive. Helium density peaks at 270 with a fat right tail toward 290-300.

Bearish Case: Term structure is backwardated (Nov ~57% vs Jan ~39-45%), signaling near-term event fear, and P/B of 9.3 leaves little room for disappointment. Deep-put IV remains extreme (85-135 strikes >130%), meaning tail protection stays bid for reimbursement/regulatory shocks. Price is -1.9% over a week with flat action; the market PDF puts meaningful mass at 240-260 (-10% to -13%). Q3 earnings and midterm Medicaid policy are binary risks.

Potential Outcomes:

• 35% Drift to 270-285 into Nov expiry — call flow, buy point at 283.05, Helium PDF mode ~270.
• 20% Breakout >290 on earnings beat/soft Medicaid cuts — 290/300C demand and +49% bullish risk support.
• 25% Pullback 240-260 — market PDF mass at 250-260; backwardated IV and 9.3x P/B mean-reversion risk.
• 12% Sharp selloff <235 — regulatory/reimbursement shock; deep-put IV >130% prices this tail.
• 8% Sideways 260-275 with IV crush post-Nov expiry.

Oracle: if 270C flow persists and price holds >275 into Nov 20, upside follow-through is favored; a 260P bid-ask widening would flag downside rotation.

October 21, 2026